Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMMA: Fluocinolone vs Dexamethasone in Resistant DME
NCT04910503Phase 4Recruiting
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Oct 2021
- Primary completion
- Apr 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluocinolone in diabetic macular edema (DME), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Oct 2021; status: recruiting.
02
Drugs
fluocinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04910503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04910503.